297
Views
2
CrossRef citations to date
0
Altmetric
REVIEWS ON LIFE AFTER CANCER FOR WOMEN

Cancer costs and gender: a snapshot of issues, trends, and opportunities to reduce inequities using Australia as an example

, , & ORCID Icon
Pages 538-543 | Received 27 May 2019, Accepted 02 Jul 2019, Published online: 05 Aug 2019

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 2018;68:394–424
  • Australian Institute of Health and Welfare. Cancer in Australia 2019. Cancer series no.119. Cat. no. CAN 123. Canberra: AIHW; 2019
  • Hanly P, Pearce A, Sharp L. The cost of premature cancer-related mortality: A review and assessment of the evidence. Expert Rev Pharmacoecon Outcomes Res 2014;14:355–77
  • Hall MT, Simms KT, Lew J-B, et al. The projected timeframe until cervical cancer elimination in Australia: A modelling study. Lancet Public Health 2019;4:e19–27
  • Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality Books. Canberra: AIHW; 2017
  • Hall PS, Hamilton P, Hulme CT, et al. Costs of cancer care for use in economic evaluation: A UK analysis of patient-level routine health system data. Br J Cancer 2015;112:948–56
  • Blakely T, Atkinson J, Kvizhinadze G, Wilson N, Davies A, Clarke P. Patterns of cancer care costs in a country with detailed individual data. Med Care 2015;53:302–9
  • Goldsbury DE, Yap S, Weber MF, et al. Health services costs for cancer care in Australia: Estimates from the 45 and Up Study. PloS One 2018;13:e0201552
  • Hanly P, Soerjomataram I, Sharp L. Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer 2015;136:E136–45
  • Laudicella M, Walsh B, Burns E, Smith PC. Cost of care for cancer patients in England: Evidence from population-based patient-level data. Br J Cancer 2016;114:1286–92
  • Fisher MD, Punekar R, Yim YM, et al. Differences in health care use and costs among patients with cancer receiving intravenous chemotherapy in physician offices vs. in hospital outpatient settings. JOP 2017;13:e37–46
  • Australian Institute of Health and Welfare. Health and Welfare Expenditure Database: AIHW; 2019. Available from: https://www.aihw.gov.au/about-our-data/our-data-collections/health-and-welfare-expenditure-database [last accessed May 2019]
  • Department of Human Services. Medicare item reports: Australian Government; 2019. Available from: http://medicarestatistics.humanservices.gov.au/statistics/mbs_item.jsp [accessed May 2019]
  • Elliott TM, Whiteman DC, Olsen CM, Gordon LG. Estimated healthcare costs of melanoma in Australia over 3 years post-diagnosis. Appl Health Econ Health Policy 2017;15:805–16
  • Jackson SE, Chester JD. Personalised cancer medicine. Int J Cancer 2015;137:262–6
  • Liljas B. How to calculate indirect costs in economic evaluations. PharmacoEconomics 1998;13:1–7
  • Chaker L, Falla A, van der Lee SJ, et al. The global impact of non-communicable diseases on macro-economic productivity: A systematic review. Eur J Epidemiol 2015;30:357–95
  • Bates N, Callander E, Lindsay D, Watt K. Labour force participation and the cost of lost productivity due to cancer in Australia. BMC Public Health 2018;18:375
  • Hanly PA, Sharp L. The cost of lost productivity due to premature cancer-related mortality: An economic measure of the cancer burden. BMC Cancer 2014;14:224
  • Carter HE, Schofield DJ, Shrestha R. The productivity costs of premature mortality due to cancer in Australia: Evidence from a microsimulation model. PloS One 2016;11:e0167521
  • Costa ES, Hyeda A. Analysis of the costs and quality of cardiovascular care in oncological monitoring. Rev Assoc Med Bras 2016;62:748–54
  • McCaffrey N. Overview: cost of cancer to the patient. Cancer Forum 2017;41:1–3
  • Gordon LG, Elliott TM, Olsen CM, Pandeya N, Whiteman DC. Patient out-of-pocket medical expenses over 2 years among Queenslanders with and without a major cancer. Aust J Primary Health 2019;24:530–6
  • Gordon LG, Ferguson M, Chambers SK, Dunn J. Fuel, beds, meals and meds: out-of-pocket expenses for patients with cancer in rural Queensland. Cancer Forum 2009;33:1–7
  • Longo CJ, Fitch M, Grignon M, McAndrew A. Understanding the full breadth of cancer-related patient costs in Ontario: A qualitative exploration. Support Care Cancer 2016;24:4541–8
  • Newton JC, Johnson CE, Hohnen H, et al. Out-of-pocket expenses experienced by rural Western Australians diagnosed with cancer. Support Care Cancer 2018;26:3543–52
  • Thompson K, Peters S, Woodward M, Carcel C, Norton R. Reporting sex and gender in medical research. Lancet 2019;393:2038
  • Kaye DR, Min HS, Herrel LA, Dupree JM, Ellimoottil C, Miller DC. Costs of cancer care across the disease continuum. Oncologist 2018;23:798–805
  • Sagar B, Lin YS, Castel LD. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective. J Med Econ 2017;20:1018–23
  • Siddiqui A, Belland L, Rivera-Reyes L, et al. A multicenter evaluation of the impact of sex on abdominal and fracture pain care. Med Care 2015;53:948
  • Peters SA, Colantonio LD, Zhao H, et al. Sex differences in high-intensity statin use following myocardial infarction in the United States. J Am Coll Cardiol 2018;71:1729–37
  • Rose TL, Deal AM, Yang H, Nielsen ME, Smith A, Milowsky MI. Gender disparities in chemotherapy use and survival in patients with metastatic bladder cancer. JCO 2015;33:e15508
  • González JR, Fernandez E, Moreno V, et al. Sex differences in hospital readmission among colorectal cancer patients. J Epidemiol Commun Health 2005;59:506–11
  • Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. JCO 2002;20:1192–202
  • Shugarman LR, Mack K, Sorbero ME, et al. Race and sex differences in the receipt of timely and appropriate lung cancer treatment. Med Care 2009;47:774–81
  • Australian Bureau of Statistics. Labour Force, Australia ABS; 2019. Available from: https://www.abs.gov.au/ausstats/[email protected]/mf/6202.0 [last accessed May 2019]
  • Pearce A, Bradley C, Hanly P, et al. Projecting productivity losses for cancer-related mortality 2011–2030. BMC Cancer 2016;16:804
  • Australian Bureau of Statistics. 4125.0 – Gender Indicators, Australia, Table 10.1: Total number of hours and minutes per day spent on work (employment related and unpaid). Canberra: ABS; 2017
  • Australian Human Rights Commission. Face the Facts: Gender equality. Sydney: Australian Human Rights Commission; 2018
  • Gordon LG, Elliott TM, Olsen CM, Pandeya N, Whiteman DC. Out-of-pocket medical expenses for Queenslanders with a major cancer. Med J Aust 2018;208:497
  • Breast Cancer Network Australia. The financial impact of breast cancer Australia BCNA; 2017.
  • Romito F, Goldzweig G, Cormio C, Hagedoorn M, Andersen BL. Informal caregiving for cancer patients. Cancer 2013;119:2160–9
  • Yabroff KR, Kim Y. Time costs associated with informal caregiving for cancer survivors. Cancer 2009;115:4362–73
  • Vos T, Carter R, Braendregt J, et al. Assessing cost-effectiveness in prevention (ACE-Prevention): Final Report. University of Queensland. Melbourne: Brisbane and Deakin University; 2010
  • Whiteman DC, Webb PM, Green AC, et al. Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions. Aust N Z J Public Health 2015;39:477–84
  • Kendall BJ, Wilson LF, Olsen CM, et al. Cancers in Australia in 2010 attributable to overweight and obesity. Aust N Z J Public Health 2015;39:452–7
  • Luo Q, Yu XQ, Wade S, et al. Lung cancer mortality in Australia: projected outcomes to 2040. Lung Cancer 2018;125:68–76
  • Arriaga ME, Vajdic CM, Canfell K, et al. The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: a pooled cohort study. Int J Cancer 2019; epub ahead of print
  • Laaksonen MA, Canfell K, MacInnis R, et al. The future burden of lung cancer attributable to current modifiable behaviours: a pooled study of seven Australian cohorts. Int J Epidemiol 2018;47:1772–83
  • Lew JB, St John DJB, Xu XM, et al. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. Lancet Public Health 2017;2:e331–40
  • Lew JB, Simms KT, Smith MA, et al. Primary HPV testing vs. cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. Lancet Public Health 2017;2:e96–e107
  • Australian Government Department of Health and Ageing. BreastScreen Australia evalulation: Evaluation final report. Canberra: Commonwealth of Australia; 2009
  • Australian Institute of Health and Welfare. National Bowel Cancer Screening Program: Monitoring report 2019. Cancer series no. 125. Cat. no. CAN 125. Canberra: AIHW; 2019
  • Australian Institute of Health and Welfare. Cervical screening in Australia 2019. Cancer series no. 123. Cat. no. CAN 124. Canberra: AIHW; 2019
  • Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2018. Cancer series no. 112. Cat. no. CAN 116. Canberra: AIHW; 2018
  • Klotz L. Prostate cancer overdiagnosis and overtreatment. Curr Opin Endocrinol Diabetes Obesity 2013;20:204–9
  • Beckmann K, Duffy SW, Lynch J, Hiller J, Farshid G, Roder D. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects. J Med Screening 2015;22:127–35
  • Wade S, Weber M, Caruana M, et al. Estimating the cost-effectiveness of lung cancer screening with low-dose computed tomography for high-risk smokers in Australia. J Thoracic Oncol 2018;13:1094–105
  • Brims F, McWilliams A, Fong K. Lung cancer screening in Australia: progress or procrastination. Med J Aust 2016;204:4–5
  • National Disability Insurance Agency. NDIS; 2019. Available from: https://www.ndis.gov.au/ [last accessed June 2019]
  • Essue BM, Beaton A, Hull C, et al. Living with economic hardship at the end of life. BMJ Support Palliative Care 2015;5:129–37
  • Paul CL, Fradgley EA, Roach D, Baird H. Impact of financial costs of cancer on patients-the Australian experience. Cancer Forum 2017;41:4–9
  • Access Economics. Cost of Cancer in NSW: A report by Access Economics Pty Limited for The Cancer Council NSW. Sydney: The Cancer Council NSW; 2007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.